Skip to content
  • Clinical Studies
  • Schedule M
  • Stability Studies
  • Pharma GMP
  • Pharma Tips
  • Pharma Books
  • Pharma Validation
  • Pharma Regulatory

SOP Guide for Pharma

The Ultimate Resource for Pharmaceutical SOPs and Best Practices

  • Home
  • SOP Guidelines
    • SOP Development
    • SOP Training
    • SOP Compliance Monitoring
    • SOP Revision Processes
    • Pharmaceutical SOP templates
    • GMP documentation SOP
    • Data integrity SOP pharma
    • Manufacturing SOP pharmaceutical
    • FDA SOP guidance
    • eQMS SOP workflows
  • Job Safety Analysis (JSA)
    • Oral Dosage Forms (Tablets & Capsules)
    • Oral Liquid Dosage Forms (Syrups, Elixirs, Suspensions, Emulsions)
    • Powder and Granule Dosage Forms
    • Topical Dosage Forms (Creams, Ointments, Gels, Lotions, Pastes)
    • Transdermal Dosage Forms (Patches)
  • Standard Test Procedures (STP)
  • GMP Audit Findings
    • Non-Compliance
      • SOP Absence
      • Revision Control
      • Non-Adherence
      • Poor Writing
      • Training Failure
      • Data Integrity Gaps
      • Mismatch Between SOPs and Practice
      • Critical Operations
      • Regulatory Change
      • Emergency Changes
      • Third-Party SOPs
      • Inspection Readiness
      • Deviation Handling
      • CAPA Integration
      • Validation Alignment
      • System Integration
      • Uncontrolled Distribution
      • SOP Implementation Gaps
      • SOP Alignment with Validation
      • Change Control Linkage
  • Toggle search form

GMP Audit Findings

GMP Risk from SOP Changes Without Corresponding Validation Updates

Posted on By

GMP Risk from SOP Changes Without Corresponding Validation Updates Ensuring SOP Changes Reflect Validation Data for GMP Compliance Introduction to the Audit Finding 1. What’s the Problem? Standard Operating Procedures (SOPs) are sometimes revised to reflect process changes or improvements. However, these changes may not be supported by corresponding validation activities — creating a gap…

Read More “GMP Risk from SOP Changes Without Corresponding Validation Updates” »

Change Control Linkage, GMP Audit Findings

GMP Risk from Inadequate Impact Assessment in Change Control SOP

Posted on By

GMP Risk from Inadequate Impact Assessment in Change Control SOP Why Impact Assessment Is Vital in Change Control SOPs Introduction to the Audit Finding 1. What Was Observed? In many audit reports, the change control SOP is found lacking clear, detailed steps for evaluating potential impact on validation, product quality, or regulatory status. 2. Why…

Read More “GMP Risk from Inadequate Impact Assessment in Change Control SOP” »

Change Control Linkage, GMP Audit Findings

Audit Risks from Delayed Closure of Change Control Records

Posted on By

Audit Risks from Delayed Closure of Change Control Records Addressing Delayed Change Control Closure in GMP Environments Introduction to the Audit Finding 1. What Was Observed? Change control records were found open well past the defined SOP closure period. This delay raised concerns regarding the effectiveness and responsiveness of the quality management system (QMS). 2….

Read More “Audit Risks from Delayed Closure of Change Control Records” »

Change Control Linkage, GMP Audit Findings

Risks of Missing SOP References in Change Control Records

Posted on By

Risks of Missing SOP References in Change Control Records Why Every Change Record Must Reference the Correct SOP Revision Introduction to the Audit Finding 1. What Was Observed? Change control records failed to explicitly mention the revised SOP number or version being impacted, updated, or implemented. 2. Why This Is a GMP Concern Creates ambiguity…

Read More “Risks of Missing SOP References in Change Control Records” »

Change Control Linkage, GMP Audit Findings

GMP Risks from Lack of Cross-Functional Review in Change Control

Posted on By

GMP Risks from Lack of Cross-Functional Review in Change Control Importance of Cross-Functional Review in Change Control Systems Introduction to the Audit Finding 1. What Was Observed? The change control process lacked a defined cross-functional review mechanism. Changes were initiated and approved within a single department without input from impacted teams. 2. Why This Is…

Read More “GMP Risks from Lack of Cross-Functional Review in Change Control” »

Change Control Linkage, GMP Audit Findings

How to Address GMP Audit Risks from Ineffective Training Evaluations

Posted on By

How to Address GMP Audit Risks from Ineffective Training Evaluations Closing Training Gaps: Evaluating the Effectiveness of GMP Training Programs Introduction to the Audit Finding 1. What Was Observed? Companies often conduct training sessions but fail to evaluate whether the training was understood and retained by employees. 2. Why This Is a GMP Risk Unverified…

Read More “How to Address GMP Audit Risks from Ineffective Training Evaluations” »

GMP Audit Findings, Training Failure

How to Strengthen Deviation Handling by Requiring Photographic Documentation

Posted on By

How to Strengthen Deviation Handling by Requiring Photographic Documentation Addressing Deviation Gaps: The Case for Requiring Photographic Evidence in GMP SOPs Introduction to the Audit Finding 1. Finding Summary Deviation SOPs in some facilities do not mandate photographic or documentary evidence when deviations occur. This gap reduces the quality and transparency of investigations. 2. Compliance…

Read More “How to Strengthen Deviation Handling by Requiring Photographic Documentation” »

Deviation Handling, GMP Audit Findings

How to Address the Absence of Escalation Process in CAPA SOPs

Posted on By

How to Address the Absence of Escalation Process in CAPA SOPs Establishing Escalation Protocols in CAPA SOPs to Prevent Deadline Breaches Introduction to the Audit Finding 1. Problem Overview Many SOPs related to CAPA management do not outline an escalation process for instances when defined deadlines are missed. 2. GMP Impact Delayed CAPA implementation undermines…

Read More “How to Address the Absence of Escalation Process in CAPA SOPs” »

CAPA Integration, GMP Audit Findings

How to Create an SOP for Temperature Excursions During Pharma Transport

Posted on By

How to Create an SOP for Temperature Excursions During Pharma Transport Developing SOPs for Managing Temperature Excursions in Pharma Logistics Introduction to the Audit Finding 1. Summary of the Issue Several GMP audits reveal that pharmaceutical companies lack documented SOPs to handle temperature excursions occurring during transport of drugs. 2. Why It Matters Failure to…

Read More “How to Create an SOP for Temperature Excursions During Pharma Transport” »

GMP Audit Findings, SOP Absence

How to Define Revalidation Triggers in Pharma SOPs

Posted on By

How to Define Revalidation Triggers in Pharma SOPs Implementing Revalidation Triggers in Operational SOPs for GMP Compliance Introduction to the Audit Finding 1. Summary of the Gap Many operational SOPs fail to clearly define when revalidation is required, creating a critical compliance risk during inspections. 2. GMP Consequences Inconsistent execution of validation activities Missed revalidation…

Read More “How to Define Revalidation Triggers in Pharma SOPs” »

GMP Audit Findings, Validation Alignment

Posts pagination

Previous 1 … 11 12

Standard Operating Procedures V 1.0

  • Aerosols
  • Analytical Method Development
  • Bioequivalence Bioavailability Study
  • Capsule Formulation
  • Clinical Studies
  • Creams
  • Data Integrity
  • Dental Dosage Forms
  • Drug Discovery
  • Environment, Health and Safety
  • Formulation Development
  • Gels
  • Good Distribution Practice
  • Good Warehousing Practices
  • In-Process Control
  • Injectables
  • Liquid Orals
  • Liposome and Emulsion Formulations
  • Lotions
  • Lyophilized Products
  • Maintenance Dept.
  • Medical Devices
  • Metered-Dose Inhaler
  • Microbiology Testing
  • Nanoparticle Formulation
  • Nasal Spray Formulations
  • Nebulizers
  • Ocular (Eye) Dosage Forms
  • Ointments
  • Otic (Ear) Dosage Forms
  • Pharmacovigilance
  • Powder & Granules
  • Purchase Departments
  • Quality Assurance
  • Quality Control
  • Raw Material Stores
  • Regulatory Affairs
  • Tablet Manufacturing
  • Rectal Dosage Forms
  • Transdermal Patches
  • Vaginal Dosage Forms
  • Validations and Qualifications

Read SOPs in your Language:

 - 
Bengali
 - 
bn
English
 - 
en
Gujarati
 - 
gu
Hindi
 - 
hi
Malayalam
 - 
ml
Marathi
 - 
mr
Punjabi
 - 
pa
Tamil
 - 
ta
Telugu
 - 
te

NEW! Revised SOPs – V 2.0

  • Aerosols V 2.0
  • Analytical Method Development V 2.0
  • API Manufacturing V 2.0
  • BA-BE Studies V 2.0
  • Biosimilars V 2.0
  • Capsules V 2.0
  • Creams V 2.0
  • Elixers V 2.0
  • Gels V 2.0
  • Injectables V 2.0
  • Ointments V 2.0
  • Raw Material Warehouse V 2.0
  • Tablet Manufacturing V2.0

New Publication: A must for All.

Copyright © 2025 SOP Guide for Pharma.

Powered by PressBook WordPress theme